Back to search

Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour

Data up to Jan 2025

Published1996
Citations1,298
References54

Total Citations Per Year

Abstract

References (54)

Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

1988 • 2,740 citations

EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION

1986 • 2,315 citations

Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1994 • 2,250 citations

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1994 • 2,186 citations

The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs.

1977 • 1,927 citations

TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION

1988 • 1,161 citations

Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia.

1994 • 1,003 citations

ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION

1992 • 898 citations

ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction

1992 • 866 citations

Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial Infarction

1983 • 805 citations

A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)

1986 • 705 citations

Prehospital-Initiated vs Hospital-Initiated Thrombolytic Therapy

1993 • 673 citations

Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial Infarction

1987 • 628 citations

Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: Results of the TIMI IIIB trial

1994 • 498 citations

IMPROVED SURVIVAL AFTER EARLY THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION

1985 • 450 citations

Prehospital Thrombolytic Therapy in Patients with Suspected Acute Myocardial Infarction

1993 • 402 citations

Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.

1988 • 386 citations

Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction

1993 • 361 citations

Cardiac rupture, mortality and the timing of thrombolytic therapy: A meta-analysis

1990 • 282 citations

The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial.

1988 • 246 citations

DOUBLE-BLIND RANDOMISED TRIAL OF INTRAVENOUS TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS PLACEBO IN ACUTE MYOCARDIAL INFARCTION

1985 • 242 citations

Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator.

1988 • 232 citations

Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial. GREAT Group.

1992 • 230 citations

The association between cardiac events and myocardial ischaemia following thrombolysis in acute myocardial infarction and the impact of carvedilol

1996 • 189 citations

Acute myocardial infarction: pre-hospital and in-hospital management: The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology

1996 • 188 citations

Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction

1993 • 165 citations

Serial angiographic assessment of coronary artery obstruction and collateral flow in acute myocardial infarction. Report from the second Mount Sinai-New York University Reperfusion Trial.

1989 • 159 citations

Reperfusion in acute myocardial infarction: Effect of timing and modulating factors in experimental models

1993 • 147 citations

Time to thrombolytic treatment: Factors affecting delay and their influence on outcome

1995 • 140 citations

Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase?

1986 • 135 citations

Temporal trends and factors associated with extent of delay to hospital arrival in patients with acute myocardial infarction: The Worcester Heart Attack Study

1994 • 127 citations

LATE assessment of thrombolytic efficacy with alteplase (rt‐PA) six‐24 hours after onset of acute myocardial infarction

1993 • 126 citations

Prehospital thrombolysis in acute myocardial infarction

1990 • 126 citations

Prehospital use of APSAC: Results of a placebo-controlled study

1989 • 126 citations

Implications for acute intervention related to time of hospital arrival in acute myocardial infarction

1986 • 124 citations

Tissue plasminogen activator: Toronto (TPAT) placebo-controlled randomized trial in acute myocardial infarction

1989 • 118 citations

Prevention of Myocardial Infarction by Very Early Treatment with Intracoronary Streptokinase

1984 • 112 citations

Myocardial reperfusion in the pig heart model: infarct size and duration of coronary occlusion

1987 • 101 citations

Influence of collateral blood flow and of variations in MV̇O2 on tissue-ATP content in ischemic and infarcted myocardium

1987 • 92 citations

Thrombolysis in patients with unstable angina improves the angiographic but not the clinical outcome. Results of UNASEM, a multicenter, randomized, placebo-controlled, clinical trial with anistreplase.

1992 • 90 citations

Tailored thrombolytic therapy. A perspective.

1993 • 84 citations

Very early thrombolytic therapy in suspected acute myocardial infarction

1990 • 79 citations

Improved survival but not left ventricular function with early and prehospital treatment with tissue plasminogen activator in acute myocardial infarction

1990 • 70 citations

Prehospital thrombolysis with alteplase (rt-PA) in acute myocardial infarction

1992 • 67 citations

Comparison of intravenous urokinase plus heparin versus heparin alone in acute myocardial infarction

1991 • 59 citations

Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex.

1986 • 46 citations

Determinants of infarct size in non-human primates

1990 • 44 citations

A double blind placebo controlled study of early and late administration of recombinant tissue plasminogen activator in acute myocardial infarction.

1989 • 40 citations

Prehospital thrombolysis in a rural community: Short- and long-term survival

1992 • 31 citations

Very early thrombolytic therapy in suspected acute myocardial infarctionThe Thrombolysis in Acute Heart Attack Trial Study Group Am J Cardiol 65:401–407 Feb 1990

1990 • 19 citations

Thrombolytic Therapy Within One Hour of the Onset of Acute Myocardial Infarction

1991 • 11 citations

Thrombolysis in refractory unstable angina

1991 • 10 citations

Peaking time of creatine-kinase MB in patients treated with urokinase or conventionally during acute myocardial infarction: is it really a clue to reperfusion?

1988 • 2 citations

Fibrinolytic therapy in suspected acute myocardial infarction

1994 • 1 citations

Cited By (0)

Loading...